Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2020
Historique:
received: 07 09 2019
accepted: 27 01 2020
pubmed: 10 4 2020
medline: 23 4 2021
entrez: 10 4 2020
Statut: ppublish

Résumé

Population-based data on survival after radical cystectomy (RC) are lacking from Southern Europe. The aim of this study was to assess trends and determinants of perioperative mortality and long-term survival in the Veneto region (Northeastern Italy). All patients submitted to RC for bladder cancer from January 2004 to December 2016 were identified from the regional archive of hospital discharge records. Age at surgery, gender, comorbidities, hospital volume, calendar period of surgery, and type of urinary diversion were retrieved; vital status and cause of death were obtained by linkage with mortality records. Determinants of 90-day mortality were assessed by multilevel logistic regression; long-term survival was investigated by the Kaplan-Meier method and Cox regression. Among 4,389 included patients, an increase in the share of patients aged ≥80 years (from 13% in 2004-2008 to 24% in 2013-2016, p < 0.001) and a decline in performing continent diversion (from 34.9 to 23.4%, p < 0.001) were observed across the study period. Ninety-day mortality did not change over time and was 4% for patients aged <70 years and 13.7% for those aged ≥80 years. Age- and comorbidities-adjusted mortality was significantly lower in hospitals performing >30 RCs/year (odds ratio 0.67, 95% confidence interval 0.48-0.93). At a median follow-up of 67 months, overall survival at 1 year and 5 years was 72 and 40%, respectively, with a higher rate among younger patients treated in high-volume hospitals. The population of patients treated with RC is rapidly ageing, with a high risk of perioperative and long-term mortality; this changing epidemiological scenario and better outcomes observed in high-volume hospitals support regionalization of the procedure.

Identifiants

pubmed: 32272471
pii: 000506240
doi: 10.1159/000506240
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-566

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Ugo Fedeli (U)

Epidemiological Department, Azienda Zero, Padova, Italy.

Angela De Paoli (A)

Epidemiological Department, Azienda Zero, Padova, Italy.

Maria Chiara Corti (MC)

Epidemiological Department, Azienda Zero, Padova, Italy.

Giovanni Enrico Cacciamani (GE)

Department of Urology, University of Verona, Verona, Italy.
USC Institute of Urology and the Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, Los Angeles, California, USA.

Inderbir S Gill (IS)

USC Institute of Urology and the Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, Los Angeles, California, USA.

Filiberto Zattoni (F)

Urologic Unit, Department of Oncologic, Surgical and Gastrointestinal Sciences, University of Padua, Padua, Italy.

Giacomo Novara (G)

Urologic Unit, Department of Oncologic, Surgical and Gastrointestinal Sciences, University of Padua, Padua, Italy.

Angelo Porreca (A)

Department of Urology, Policlinico Abano Terme, Abano Terme, Italy.

Walter Artibani (W)

Department of Urology, University of Verona, Verona, Italy, walter.artibani@univr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH